Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

DaVita HealthCare Partners Inc

TRL
Current price
136.2 EUR -2.14 EUR (-1.55%)
Last closed 147.07 USD
ISIN US23918K1088
Sector Healthcare
Industry Medical Care Facilities
Exchange Frankfurt Exchange
Capitalization 11 613 777 920 USD
Yield for 12 month +77.30 %
1Y
3Y
5Y
10Y
15Y
TRL
21.11.2021 - 28.11.2021

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. Address: 2000 16th Street, Denver, CO, United States, 80202

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

160.39 USD

P/E ratio

15.274

Dividend Yield

Current Year

+12 140 147 000 USD

Last Year

+11 609 894 000 USD

Current Quarter

+3 263 590 000 USD

Last Quarter

+3 186 722 000 USD

Current Year

+3 074 987 000 USD

Last Year

+3 400 341 000 USD

Current Quarter

+924 701 000 USD

Last Quarter

+868 762 000 USD

Key Figures TRL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 2 657 765 120 USD
Operating Margin TTM 16.28 %
PE Ratio 15.274
Return On Assets TTM 6.94 %
PEG Ratio 1.067
Return On Equity TTM 44.88 %
Wall Street Target Price 160.39 USD
Revenue TTM 12 666 613 760 USD
Book Value 4.68 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 4.6 %
Dividend Yield
Gross Profit TTM 3 400 341 000 USD
Earnings per share 9.27 USD
Diluted Eps TTM 9.27 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -4.6 %
Profit Margin 6.53 %

Dividend Analytics TRL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TRL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 2:1
Payout Ratio
Last Split Date 09.09.2013
Dividend Date

Stock Valuation TRL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 15.274
Forward PE 12.3762
Enterprise Value Revenue 1.7937
Price Sales TTM 0.9169
Enterprise Value EBITDA 8.8107
Price Book MRQ 30.0319

Financials TRL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TRL

For 52 weeks

78.05 USD 168.5 USD
50 Day MA 157.78 USD
Shares Short Prior Month 5 228 078
200 Day MA 139.8 USD
Short Ratio 5.88
Shares Short 4 304 558
Short Percent 9.51 %